Delivery Order SPE2DB22D1106-SPE2DB25FEQV9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,418.00 for 10,000 unit vials of Pregnyl on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price contract represents a non-set-aside award executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pregnyl 10,000 unit vials, with a ceiling value of $1,813.50. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.42 to AmerisourceBergen Drug Corp for 10,000-unit vials of Pregnyl, a human chorionic gonadotropin medication. The contract, awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $2,418 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,022.50 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- This delivery order, valued at $7,254.00, was awarded to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pregnyl 10,000 unit vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a child contract under a larger federal procurement vehicle. The award was made without a set-aside designation, indicating open competition. The place of performance is located in Conshohocken, Pennsylvania, the headquarters of...
- This delivery order, valued at $2,418.00, was awarded on July 30, 2025, to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. The contract, which is not set-aside and carries a firm fixed price structure, will be performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The Defense Logistics Agency (DLA), under the Department of Defense, issued this award as part of its ongoing pharmaceutical procurement...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQV9Delivery Order
The Defense Logistics Agency awarded a $2,418.00 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Pregnyl 10,000 unit vials, with an ultimate completion date of June 2, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply needs across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Pregnyl, a human chorionic gonadotropin hormone treatment, aligns with AmerisourceBergen's established role as a primary supplier of pharmaceutical products through the DLA Medical Supply Chain, supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/30/25 |